Monday, 20 May 2019

Perrigo launches medication for Frequent Heartburn

13 April 2018 | News

Omeprazole ODT is an FDA-approved medication, featuring MelTech melt-in-your-mouth technology that dissolves in the mouth without water

Perrigo and its Israel based partner, Dexcel Pharma announced the launch of store brand omeprazole delayed release orally disintegrating tablets 20mg (omeprazole ODT), an over-the-counter (OTC) medication to treat frequent heartburn.

Omeprazole ODT is an FDA-approved medication, featuring MelTech melt-in-your-mouth technology that dissolves in the mouth without water.

This product is packaged and marketed as a store brand or retailer 'own label' brand and will provide consumers with a high-quality option for treating frequent heartburn. 

"Consumers want a heartburn medication that provides effective, long-term relief, but they also want a product that is easy and convenient to take," said Jeff Needham, executive vice president and president, consumer healthcare Americas. 

According to IRI, retail sales of omeprazole (as an active ingredient) are more than $600 million for the last 12 months, when combining store brand and the nationally advertised brand, Prilosec OTC.

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Podcast

 

Survey Box

Will stem cell therapy market witness highest growth in Asia by 2020?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls